Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Colonic Neoplasms × regorafenib × Clear all

Status

Sponsor Class

Study Type

Interventional 9 Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 12 Carcinoma, Hepatocellular 4 Liver Neoplasms 3 TAS 102 1 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Colorectal Adenocarcinoma 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Colonic Neoplasms 1 COVID-19 1 Advanced Gastrointestinal Stromal Tumor 1 Advanced Colorectal Carcinoma 1

Interventions

Surveys and Questionnaires 11 Blood Specimen Collection 10 Colonoscopy 7 Psychiatric Rehabilitation 6 Immunohistochemistry 6 Drug Therapy 5 Polymerase Chain Reaction 4 Mental Status and Dementia Tests 4 Colectomy 4 Biopsy 4 Amplified Fragment Length Polymorphism Analysis 4 Watchful Waiting 3 Magnetic Resonance Spectroscopy 3 Immunoenzyme Techniques 3 Gene Expression Profiling 3 Exercise 3 Endoscopic Mucosal Resection 3 Chromosome Mapping 3 Bevacizumab 3 Surgical Procedures, Operative 2 Specimen Handling 2 Reverse Transcriptase Polymerase Chain Reaction 2 Radiotherapy 2 Polyethylene Glycols 2 Observation 2 Microarray Analysis 2 Mass Spectrometry 2 Laparoscopy 2 Irinotecan 2 Interviews as Topic 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05839951 2025-11-12

STAR-T

Bayer

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡